Terbutaline Sulfate
Product Images NDC 0404-9778

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Terbutaline Sulfate (NDC 0404-9778). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Formula1.jpg (Formula1)
Not available.*
FDA Label Image

Image1.jpg (Image1)

Image1.jpg (Image1)
This is a table presenting the incidence (%) of adverse reactions associated with two medications, Terbutaline and Epinephrine, at different doses. The reactions are categorized under different systems, including Central Nervous System, Cardiovascular, Respiratory, Gastrointestinal, and Systemic. Each adverse reaction is listed with the corresponding percentage for each medication and dose.*
FDA Label Image

Label1.jpg (Lablel 1)

Label1.jpg (Lablel 1)
This is a product information label for Terbutaline Sulfate. It includes directions for use and dosage information. The text mentions the recommended single dose and provides space to write the date opened. Additionally, it includes a lot number and expiration date. The label states "RX ONLY" indicating it is prescription medication.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.